Feature Channels: Men's Health

• share
• favorite_border

VCU Health radiologist Jinxing Yu, M.D., uses magnetic resonance technology to diagnose with more than 90 percent success rate.

• share
• favorite_border

Click here to go directly to the Cardiovascular Health News Source

• share
• favorite_border

The Center for Behavioral Neuroscience (CBN) at Georgia State University has received a five-year, $3.2 million grant from the National Institute of Mental Health to investigate the neurochemical mechanisms underlying social stress in males and females.

• share
• favorite_border

• share
• favorite_border

The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004 to 2013, reports a new Northwestern Medicine study. The authors suspect the recent trend of fewer men being screened and more aggressive disease may be contributing to the rise. The largest increase in new cases was among men 55 to 69 years old, which rose 92 percent in the past decade. This rise is troubling because men in this age group are believed to benefit most from prostate cancer screening and early treatment.

• share
• favorite_border

Increasing the number of men who undergo circumcision and increasing the rates at which women with HIV are given antiretroviral therapy (ART) were associated with significant declines in the number of new male HIV infections in rural Ugandan communities, new Johns Hopkins Bloomberg School of Health research suggests.

• share
• favorite_border

With commercial sperm banking giving women more opportunities to become mothers, a world-first QUT study has found the age and education of sperm donors are the most important characteristics considered.

• share
• favorite_border

Men with metastatic prostate cancer should be considered for germline genetic testing of DNA repair genes, regardless of age or family history, according to a team of researchers from Memorial Sloan Kettering Cancer Center (MSK), Fred Hutchinson Cancer Research Center, Dana-Farber Cancer Institute, University of Washington School of Medicine, University of Michigan, and the Institute of Cancer Research Royal Marsden Hospital.

• share
• favorite_border

This groundbreaking study revealed that more than 10 percent of men with aggressive prostate cancer that has spread outside of the prostate have inherited mutations in DNA repair genes — more than four times the rate of the general population and more than twice the rate of men with localized prostate cancer. Men with such mutations could benefit from targeted treatment already approved for ovarian cancer patients with these mutations, such as PARP inhibitors or platinum drugs.

• share
• favorite_border

When women feel a lump in their breast, they usually seek medical attention within a few weeks. Yet men who notice something abnormal in a testicle typically don't see a doctor for two to three months.

• share
• favorite_border

Older men with low libido and low testosterone levels showed more interest in sex and engaged in more sexual activity when they underwent testosterone therapy, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

• share
• favorite_border

Men who sleep either fewer or more hours than average may face a greater risk of developing diabetes, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism.

• share
• favorite_border

Researchers at the Ontario Institute for Cancer Research (OICR) and University Health Network (UHN) in Toronto, along with researchers at the Eastern Virginia Medical School, have created protein signatures that accurately diagnose prostate cancer and can distinguish between patients with aggressive versus non-aggressive disease using a simple urine sample.

• share
• favorite_border

Prostate cancer researchers have discovered biomarkers using non-invasive liquid biopsies to identify aggressive disease before surgery.

• share
• favorite_border

NYU Lutheran is determined to help stop prostate cancer in its tracks. And leading NYU Lutheran’s fight is Marc Bjurlin, DO, the hospital’s newly appointed director of urologic oncology and clinical assistant professor of urology at NYU School of Medicine.

• share
• favorite_border

In an effort to address widespread concerns related to testosterone deficiency (TD) and its treatment with testosterone therapy, a group of international experts has developed a set of resolutions and conclusions to provide clarity for physicians and patients. At a consensus conference held in Prague, Czech Republic last fall, the experts debated nine resolutions, with unanimous approval. The details of the conference were published today in a Mayo Clinic Proceedings report.

• share
• favorite_border

• share
• favorite_border

Women live longer than men. This simple statement holds a tantalizing riddle that Steven Austad, Ph.D., and Kathleen Fischer, Ph.D., of the University of Alabama at Birmingham explore in a perspective piece published in Cell Metabolism on June 14.

• share
• favorite_border

Prostate cancer patients may soon have a new option to treat their disease: laser heat. UCLA researchers have found that focal laser ablation – the precise application of heat via laser to a tumor – is both feasible and safe in men with intermediate risk prostate cancer.

• share
• favorite_border

Publication in Genes & Development: researchers at the Université libre de Bruxelles, ULB develop new techniques to assess the fate of stem cells in vivo.